Estrogenic compounds as anti-mitotic agents
First Claim
Patent Images
1. A method for treating a mammalian disease characterized by undesirable cell mitosis, said method comprising administering to a mammal a compound of the formula below, said compound being administered in an amount sufficient to inhibit tubulin polymerization or depolymerization:
- ##STR4## wherein;
I. Ra -Ro are defined as follows;
A) each Ra, Rb, Rc, Rd, Re, Rf, Ri, Rj, Rk, RL, Rm, Ro, independently is --R1, --OR1, --OCOR1, --SR1, --F, --NHR2, --Br, or --I; and
Rg is --R1, --OR1, --OCOR1, --SR1, --F, --NHR2, --Br, --I, or --C.tbd.CH;
orB) each Ra, Rb, Rc, Rf, Rk, RL Ro, independently is --R1, --OR1, --OCOR1, --SR1, --F, --NHR2, --Br, or --I; and
each Rd, Re, Ri, Rj, Rm, independently is ═
O, --R1, --OR1, --OCOR1, --SR1, --F, NHR2, --Br or --I; and
Rg is ═
O, --R1, --OR1, --OCOR1, --SR1, --F, --NHR2, --Br, --I, or --C.tbd.CH; and
II. Z'"'"' is defined as follows;
##STR5## and III. Z" is defined as follows;
Z" is Y, where Y is ##STR6## where n is 0-6;
IV. provided that when each Rb, Rc, Rd, Re, Ri, Rj, Rk, RL, Rm and Ro is H;
Rf is --CH3 ;
Rg is --OH;
Z'"'"' is >
CHOH; and
Z" is >
CH2 ;
then Ra is not --H; and
V. provided that when each Rb, Rc, Rd, Re, Ri, Rj, Rk, RL, Rm and Ro is H;
Rf is --CH3 ;
Rg is OH;
Z'"'"' is >
COH; and
Z" is >
CH2 ;
then Ra is not OCH3 ;
where, in each formula set forth above, each R1 and R2 independently is --H, or an alkyl, alkenyl or alkynl group of up to 6 carbons.
0 Assignments
0 Petitions
Accused Products
Abstract
The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.
-
Citations
8 Claims
-
1. A method for treating a mammalian disease characterized by undesirable cell mitosis, said method comprising administering to a mammal a compound of the formula below, said compound being administered in an amount sufficient to inhibit tubulin polymerization or depolymerization:
- ##STR4## wherein;
I. Ra -Ro are defined as follows;A) each Ra, Rb, Rc, Rd, Re, Rf, Ri, Rj, Rk, RL, Rm, Ro, independently is --R1, --OR1, --OCOR1, --SR1, --F, --NHR2, --Br, or --I; and
Rg is --R1, --OR1, --OCOR1, --SR1, --F, --NHR2, --Br, --I, or --C.tbd.CH;
orB) each Ra, Rb, Rc, Rf, Rk, RL Ro, independently is --R1, --OR1, --OCOR1, --SR1, --F, --NHR2, --Br, or --I; and
each Rd, Re, Ri, Rj, Rm, independently is ═
O, --R1, --OR1, --OCOR1, --SR1, --F, NHR2, --Br or --I; and
Rg is ═
O, --R1, --OR1, --OCOR1, --SR1, --F, --NHR2, --Br, --I, or --C.tbd.CH; andII. Z'"'"' is defined as follows;
##STR5## and III. Z" is defined as follows;Z" is Y, where Y is ##STR6## where n is 0-6;
IV. provided that when each Rb, Rc, Rd, Re, Ri, Rj, Rk, RL, Rm and Ro is H;Rf is --CH3 ; Rg is --OH; Z'"'"' is >
CHOH; andZ" is >
CH2 ;then Ra is not --H; and V. provided that when each Rb, Rc, Rd, Re, Ri, Rj, Rk, RL, Rm and Ro is H; Rf is --CH3 ; Rg is OH; Z'"'"' is >
COH; andZ" is >
CH2 ;then Ra is not OCH3 ; where, in each formula set forth above, each R1 and R2 independently is --H, or an alkyl, alkenyl or alkynl group of up to 6 carbons. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
- ##STR4## wherein;
Specification